• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 06, 2024 at 08:02: PM
via The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration during general anesthesia or deep sedation, Medscape reported Nov. 6.

article source
 






Top Bottom
Back
Quote